News from the EU
- Potentially life-threatening accidental exposure to fentanyl patches (Durogesic® etc.)
- Combined use of medicines affecting the renin-angiotensin system (RAS) is restricted
- EU starts review of cardiovascular risks from long-term use with high doses of ibuprofen
- EU's list of recommendations on safety signals
News from the DHMA
- Dose errors involving fosphenytoin (Pro-Epanutin)
- Olanzapine prolonged-release injection (Zypadhera®) and post-injection syndrome
- Childhood vaccinations and adverse reactions in Q1 of 2014
News in brief
- Most recent Direct Healthcare Professional Communications (DHPCs)